
Biochemical Immunology of Diabetes and Associated Complications
- 1st Edition - March 15, 2024
- Imprint: Academic Press
- Editors: Pratima Tripathi, Rama Pati Tripathi, Mahabir Parshad Kaushik
- Language: English
- Paperback ISBN:9 7 8 - 0 - 4 4 3 - 1 3 1 9 5 - 0
- eBook ISBN:9 7 8 - 0 - 4 4 3 - 1 3 1 9 6 - 7
Biochemical Immunology of Diabetes and Associated Complications offers in-depth coverage of the association of biochemical and immunological aspects of the human body in diabet… Read more

Purchase options

Institutional subscription on ScienceDirect
Request a sales quote- Presents information on Immunosuppression and Immunomodulation that directly or indirectly affects the biochemistry underlying diabetes
- Highlights the association of immunological and biochemical aspects in diabetes to gain a better understanding in handling the disease
- Presents the latest research on inflammatory-mediated responses in the development of diabetes
- Includes a chapter of Case studies related to the diseases in question
- Cover image
- Title page
- Table of Contents
- Copyright
- Dedication
- Contributors
- About the editor
- Foreword
- Preface
- Acknowledgments
- Introduction
- Chapter 1. Types of diabetes mellitus, mechanism of insulin resistance and associated complications
- 1. Introduction to diabetes mellitus
- 2. Insulin resistance
- Chapter 2. Immune system and diabetes mellitus
- 1. Introduction
- 2. Apoptosis of pancreatic B-cells and insulin deficiency
- 3. Hyperglycemia and immune dysfunction
- 4. Hyperglycemia and immune dysfunction
- 5. Dysfunction of adaptive immunity in hyperglycemia
- 6. Susceptibility to infections in diabetics
- Chapter 3. Type-2 Diabetes Mellitus and its effect on immune system
- 1. Introduction
- 2. Effects on innate immunity
- 3. Impairment of adaptive immunity in T2DM
- 4. Effects of T2DM on the susceptibility of patients to infections
- 5. Conclusion
- Chapter 4. Association of oxidative stress and diabetes mellitus
- 1. Introduction
- 2. Role and sources of oxidative stress in diabetes
- 3. Role of oxidative stress in pathophysiology of diabetes mellitus
- 4. Mechanisms of hyperglycemia-induced damage
- 5. Biomarkers of oxidative stress in diabetes
- 6. Therapy interventions for diabetic oxidative stress
- 7. Conclusion
- Chapter 5. Biochemical pathways involved in diabetes mellitus
- 1. Introduction
- 2. Insulin signaling pathways
- 3. The phosphatidylinositol 3-kinase (PI3K, a lipid kinase)/AKT
- 4. The MAPK signaling pathway
- 5. Carbohydrate metabolism and diabetes
- 6. Lipid metabolism and insulin resistance
- 7. Conclusion
- Chapter 6. Immune response and biochemical connection in diabetes mellitus
- 1. Introduction
- 2. Role of immune cell signaling on insulin resistance
- 3. Apoptosis of pancreatic cells and hyperglycemia
- 4. Immune suppression in diabetes
- 5. Defects in cellular immune response
- 6. Conclusion
- Chapter 7. Immunomodulatory therapy in diabetes mellitus: A pharmacological approach
- 1. Introduction
- 2. Immunomodulation in type 1 diabetes
- 3. Immunomodulation in type 2 diabetes
- 4. Diabetic complications
- Chapter 8. Targeting immune system for the treatment of diabetes mellitus
- 1. Introduction
- 2. Immune system and tolerance
- 3. Genetic susceptibility
- 4. Autoantibodies in type 1 diabetes
- 5. Immunotherapy trials
- 6. Conclusion
- Chapter 9. GPCRs as therapeutic targets for the treatment of diabetes mellitus
- 1. G-protein-coupled receptors
- 2. Diabetes mellitus
- 3. Role of GPCRs in insulin production: Fig. 9.2
- 4. Incretins, DPP-4 inhibitors, and their roles in diabetes: Fig. 9.3
- 5. Novel treatments: Table 9.1
- 6. Conclusion
- Abbreviations
- Chapter 10. Biochemistry and immunology of inflammation-mediated responses in the development of diabetes mellitus
- 1. Introduction
- Chapter 11. Association of diabetes mellitus with stress, neuroinflammation, and other comorbid neuropsychiatric disorders: An immunological perspective
- 1. Introduction
- 2. Immune system–related neuronal inflammation and diabetes mellitus
- 3. Immune system–related other comorbid diseases of psychiatric disorder and diabetes mellitus
- 4. Conclusion
- Chapter 12. Potent inflammatory biomarkers in insulin resistance
- 1. Introduction
- 2. Conclusion
- Chapter 13. Eliminating the knowledge gap of overlapped mechanisms of diabetes and neurological disorders
- 1. Introduction
- 2. Diabetes and inflammatory neurological/cognitive disorders
- 3. Diabetes and hepatotoxicity
- Abbreviations
- Chapter 14. Role of symbiotics in the treatment of diabetes mellitus via modification of the immune system
- 1. Introduction
- 2. Link between gut microbiota and diabetes mellitus
- 3. Symbiotics
- 4. Novel symbiotic therapy in diabetes treatment
- 5. Conclusion
- Chapter 15. Effect of current antidiabetic drugs on inflammation and immune system
- 1. Introduction
- 2. Antidiabetic drugs
- 3. Conclusion
- Chapter 16. Lifestyle modifications and nutritional modulation of immune system for prevention and management of diabetes mellitus: Current perspectives
- 1. Introduction
- 2. Lifestyle modifications for glycemic control and immunomodulation
- 3. Conclusion
- Chapter 17. Cellular and molecular mechanisms of the antidiabetic drugs under clinical trials
- 1. Introduction
- 2. Drug acting on incretin pathway
- 3. SGLT2 inhibitors (gliflozins)
- 4. Newer insulin formulations
- 5. Glimins
- 6. GKAs: Glucokinase activators (GKAs) gliatins
- 7. Glycogen synthase kinase-3 (GSK3)
- 8. Probiotics
- 9. Mitochondrial membrane transporter inhibitors
- 10. Stem cell therapy
- 11. Gene therapy
- Chapter 18. Gut microbiota and diabetes: Exploring the intricate connection
- 1. Introduction
- 2. Diabetes and its types
- 3. Type 1 diabetes (T1DM)
- 4. Type 2 diabetes mellitus (T2DM)
- 5. Gestational diabetes (GDM)
- 6. Role of the gut microbiota
- 7. Gut microbiota composition
- 8. Gut microbiota dysbiosis
- 9. Gut permeability (leaky gut)
- 10. Dysbiosis in type 1 diabetes (T1DM)
- 11. Dysbiosis in type 2 diabetes
- 12. Dysbiosis in gestational diabetes
- 13. Changes in microbial composition and their implications
- 14. Animal models and experimental evidence
- 15. Gut microbiota as a therapeutic target
- 16. Lifestyle interventions for diabetes management
- 17. Lifestyle education and support
- 18. Future perspectives in targeting the gut microbiome for diabetes
- Glossary
- Index
- Edition: 1
- Published: March 15, 2024
- No. of pages (Paperback): 442
- No. of pages (eBook): 340
- Imprint: Academic Press
- Language: English
- Paperback ISBN: 9780443131950
- eBook ISBN: 9780443131967
PT
Pratima Tripathi
Currently Dr. Pratima is serving as an Assistant Professor in the Department of Biotechnology at National Institute of Pharmaceutical Education and Research (NIPER), Raebareli. Pratima earned her Ph.D. in Biochemistry from University of Lucknow, Lucknow, Uttar Pradesh in 2012. Her doctoral research oriented on ‘Therapeutic Role of L-arginine on free radical scavenging system in ischemic heart diseases.’ During her research, she investigated the vivid role of L-arginine as a significant therapeutic in mitigating the oxidant-antioxidant imbalance that arises during oxidative stress condition and oxygen insult that contributes in the pathogenesis of myocardial infarction induced ischemia and further complications. She contributed her research outputs as publications in high impact journals of repute. The scholar has also been bestowed with ‘Young Scientist Award’ in 2010 from the Society for Immunology and Immunopathology, India.
She had a stint teaching experience in Sri Sathya Sai Institute of Higher Learning (SSSIHL), Anantapur as an Assistant Professor from 2012 to 2017. After gaining a rich experience in Southern India, she relocated to her home town, Lucknow and served as Guest faculty at Integral University, Lucknow till May 2019.
The dynamic phase of her academic career and her zeal towards scientific research granted her a good opportunity as ICMR-Research associateship and Principal Investigator on the project “The role of highly sensitive Troponin-I, highly sensitive C Reactive Protein and NT-proBNP in predicting coronary artery stenosis in patients undergoing Coronary Artery Angiography.”
The ICMR research project was focused on biomarker profiling and analysis of different cardiac and inflammatory biomarkers in coronary artery disease patients to investigate the correlation between the extent of vascular stenosis and level of biomarkers. Research outcome from the work conducted by Pratima as Postdoctoral fellow at Dr. Ram Manohar Lohia Institute of Medical Sciences, Lucknow from 2019 to 2021 was utilized for setting up hs-TnI as a profiling marker at DRMLIMS in 2021 as is currently a part of routine blood test for all the CVD patients at DRMLIMS and associated clinical setups.
In 2021, she joined National Institute of Pharmaceutical Education and Research (NIPER), Raebareli as an Assistant Professor in the Department of Biotechnology. The institute offered her acumen a good scope in both academic cum administrative aspects with a magnified research spectrum. Her research team works in the area of pharmaceutical biotechnology and is focused on drug discovery and development. The team formulated nanocarriers and drug conjugates for efficient transport of drugs; artemisinin and berginin and studied the impact of these formulations in mitigating diabetes induced inflammatory complications.
RT
Rama Pati Tripathi
MK